{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:46:24Z","timestamp":1791398784511,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.antiviral.2014.01.018","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T14:31:47Z","timestamp":1391265107000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Small molecule inhibition of Epstein\u2013Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome"],"prefix":"10.1016","volume":"104","author":[{"given":"Eun Kyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Won","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hye","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Kieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-9305","authenticated-orcid":false,"given":"Myung-Soo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.01.018_b0005","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1073\/pnas.72.4.1477","article-title":"Epstein-\u2013Barr virus genomes with properties of circular DNA molecules in carrier cells","volume":"72","author":"Adams","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0010","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1128\/jvi.65.3.1466-1478.1991","article-title":"Functional domains of Epstein\u2013Barr virus nuclear antigen EBNA-1","volume":"65","author":"Ambinder","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2144\/98245bm14","article-title":"Modified Hirt procedure for rapid purification of extrachromosomal DNA from mammalian cells","volume":"24","author":"Arad","year":"1998","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2014.01.018_b0020","doi-asserted-by":"crossref","first-page":"e1000469","DOI":"10.1371\/journal.ppat.1000469","article-title":"Zinc coordination is required for and regulates transcription activation by Epstein\u2013Barr nuclear antigen 1","volume":"5","author":"Aras","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.01.018_b0025","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1212\/WNL.43.11.2358","article-title":"Expression of Epstein\u2013Barr virus proteins in primary CNS lymphoma in AIDS patients","volume":"43","author":"Bashir","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.antiviral.2014.01.018_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0092-8674(95)90232-5","article-title":"Crystal structure of the DNA-binding domain of the Epstein\u2013Barr virus origin-binding protein EBNA 1","volume":"83","author":"Bochkarev","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.01.018_b0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0092-8674(00)81056-9","article-title":"Crystal structure of the DNA-binding domain of the Epstein\u2013Barr virus origin-binding protein, EBNA1, bound to DNA","volume":"84","author":"Bochkarev","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.01.018_b0040","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1006\/jmbi.1998.2247","article-title":"The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein\u2013Barr virus origin binding protein, EBNA1","volume":"284","author":"Bochkarev","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00002030-200106150-00005","article-title":"Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin\u2019s lymphoma in the brain","volume":"15","author":"Bossolasco","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2014.01.018_b0050","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/JVI.73.2.1555-1564.1999","article-title":"X-Linked agammaglobulinemia patients are not infected with Epstein\u2013Barr virus: implications for the biology of the virus","volume":"73","author":"Faulkner","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0055","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0021-9258(17)42220-4","article-title":"Stabilization of the EBNA1 protein on the Epstein\u2013Barr virus latent origin of DNA replication by a DNA looping mechanism","volume":"269","author":"Frappier","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.01.018_b0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ijc.2910290406","article-title":"Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt\u2019s lymphoma","volume":"29","author":"Geser","year":"1982","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2014.01.018_b0065","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/jvi.67.6.3418-3426.1993","article-title":"Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein\u2013Barr virus latent origin of DNA replication","volume":"67","author":"Goldsmith","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1309\/MMAU-0QYH-7BHA-W8C2","article-title":"Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein\u2013Barr virus in Hodgkin lymphoma","volume":"117","author":"Gulley","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0075","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1073\/pnas.80.7.1987","article-title":"Chromosome site for Epstein\u2013Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro","volume":"80","author":"Henderson","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0080","first-page":"427","article-title":"Epstein\u2013Barr virus-related serology in nasopharyngeal carcinoma and controls","volume":"20","author":"Henle","year":"1978","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.antiviral.2014.01.018_b0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0022-2836(67)90307-5","article-title":"Selective extraction of polyoma DNA from infected mouse cell cultures","volume":"26","author":"Hirt","year":"1967","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-005-0036-x","article-title":"Suppression of Epstein\u2013Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt\u2019s lymphoma cells","volume":"132","author":"Hong","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0095","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1073\/pnas.98.4.1865","article-title":"Maintenance of Epstein\u2013Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1","volume":"98","author":"Hung","year":"2001","journal-title":"Proc. Natl. Acad. Sci.U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0100","first-page":"367","article-title":"Genomic integration as a novel mechanism of EBV persistence","volume":"166","author":"Hurley","year":"1990","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0105","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1128\/jvi.65.7.3958-3963.1991","article-title":"The prototypical Epstein\u2013Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA","volume":"65","author":"Hurley","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2222\/jsv.55.239","article-title":"Therapeutic inhibition of Epstein\u2013Barr virus-associated tumor cell growth by dominant-negative EBNA1","volume":"55","author":"Imai","year":"2005","journal-title":"Uirusu"},{"key":"10.1016\/j.antiviral.2014.01.018_b0115","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.211556598","article-title":"Epstein\u2013Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth","volume":"98","author":"Kang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0120","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.0408774102","article-title":"Epstein\u2013Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice","volume":"102","author":"Kang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0125","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/JVI.02596-07","article-title":"Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL\/6J mice","volume":"82","author":"Kang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0130","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1128\/JVI.01628-10","article-title":"Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance","volume":"85","author":"Kang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0135","unstructured":"Kieff, E.D., Rickinson, A.B., 2007. Epstein-Barr Virus and Its Replication. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology. Lippincott WIlliams and WIlkins, a Wolters Kluwer Business, Philadelphia, pp. 2603\u20132654."},{"key":"10.1016\/j.antiviral.2014.01.018_b0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbrc.2012.06.095","article-title":"Small molecule and peptide-mediated inhibition of Epstein\u2013Barr virus nuclear antigen 1 dimerization","volume":"424","author":"Kim","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2014.01.018_b0145","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1128\/JVI.72.11.9150-9156.1998","article-title":"Epstein\u2013Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt\u2019s lymphoma cell line Akata","volume":"72","author":"Komano","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/jm0302997","article-title":"Evaluation of docking performance: comparative data on docking algorithms","volume":"47","author":"Kontoyianni","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.01.018_b0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0092-8674(88)90530-2","article-title":"Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line","volume":"52","author":"Lawrence","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.01.018_b0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(89)90924-0","article-title":"Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization","volume":"57","author":"Lawrence","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.01.018_b0165","first-page":"97","article-title":"B-lymphoblastoid cell lines from cancer patients. In vitro cellular and developmental biology","volume":"34","author":"Lee","year":"1998","journal-title":"Animal"},{"key":"10.1016\/j.antiviral.2014.01.018_b0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000134416","article-title":"High-resolution FISH of the entire integrated Epstein\u2013Barr virus genome on extended human DNA","volume":"74","author":"Lestou","year":"1996","journal-title":"Cytogenetics Cell Genet."},{"key":"10.1016\/j.antiviral.2014.01.018_b0175","doi-asserted-by":"crossref","first-page":"e10126","DOI":"10.1371\/journal.pone.0010126","article-title":"Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening","volume":"5","author":"Li","year":"2010","journal-title":"PLOS ONE"},{"key":"10.1016\/j.antiviral.2014.01.018_b0180","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ijc.2910130605","article-title":"Relationship between Epstein\u2013Barr virus (EBV) DNA and the EBV- determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies","volume":"13","author":"Lindahl","year":"1974","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2014.01.018_b0185","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0140-6736(91)91837-K","article-title":"Epstein\u2013Barr virus in AIDS-related primary central nervous system lymphoma","volume":"338","author":"MacMahon","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.01.018_b0190","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1128\/JVI.73.5.4385-4392.1999","article-title":"Mapping EBNA-1 domains involved in binding to metaphase chromosomes","volume":"73","author":"Marechal","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0195","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.6095452","article-title":"Persistence of the entire Epstein\u2013Barr virus genome integrated into human lymphocyte DNA","volume":"226","author":"Matsuo","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.01.018_b0200","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.micinf.2008.04.002","article-title":"Induction of apoptosis in Epstein\u2013Barr virus-infected B-lymphocytes by the NF-kappaB inhibitor DHMEQ","volume":"10","author":"Miyake","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2014.01.018_b0205","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ymthe.2004.12.017","article-title":"Eradication of Epstein\u2013Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1","volume":"11","author":"Nasimuzzaman","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2014.01.018_b0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/newbio238169a0","article-title":"Separation of Epstein\u2013Barr virus DNA from large chromosomal DNA in non- virus-producing cells","volume":"238","author":"Nonoyama","year":"1972","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0215","doi-asserted-by":"crossref","first-page":"10336","DOI":"10.1128\/JVI.00747-09","article-title":"Role for G-quadruplex RNA binding by Epstein\u2013Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment","volume":"83","author":"Norseen","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0220","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0092-8674(85)90282-X","article-title":"Sequence-specific DNA binding of the Epstein\u2013Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region","volume":"42","author":"Rawlins","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.01.018_b0225","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/1078-0432.CCR-04-2264","article-title":"In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202","volume":"11","author":"Raynaud","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.01.018_b0230","first-page":"3838","article-title":"Trans activation of an Epstein\u2013Barr viral transcriptional enhancer by the Epstein\u2013Barr viral nuclear antigen 1","volume":"6","author":"Reisman","year":"1986","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0235","unstructured":"Rickinson, A.B., Kieff, E.D., 2007. Epstein-Barr Virus, in: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, a Wolters Kluwer Business, Philadelphia, pp. 2655\u20132700."},{"key":"10.1016\/j.antiviral.2014.01.018_b0240","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1182\/blood-2004-01-0342","article-title":"Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein\u2013Barr virus pathogenesis in the immunosuppressed host","volume":"104","author":"Rivailler","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2014.01.018_b0245","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood.V84.2.582.582","article-title":"Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein\u2013Barr virus-immortalized B cells","volume":"84","author":"Roth","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2014.01.018_b0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1568005053174609","article-title":"Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs","volume":"5","author":"Schang","year":"2005","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"10.1016\/j.antiviral.2014.01.018_b0255","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1128\/JVI.77.21.11767-11780.2003","article-title":"Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein\u2013Barr nuclear antigen 1","volume":"77","author":"Sears","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0260","doi-asserted-by":"crossref","first-page":"11487","DOI":"10.1128\/JVI.78.21.11487-11505.2004","article-title":"The amino terminus of Epstein\u2013Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes","volume":"78","author":"Sears","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0265","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/jvi.66.6.3355-3362.1992","article-title":"Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions","volume":"66","author":"Shah","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0270","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/jvi.68.9.6069-6073.1994","article-title":"Isolation of Epstein\u2013Barr virus (EBV)-negative cell clones from the EBV- positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV","volume":"68","author":"Shimizu","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0275","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/306480a0","article-title":"Replication of Epstein\u2013Barr virus in human epithelial cells infected in vitro","volume":"306","author":"Sixbey","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.01.018_b0280","first-page":"410","article-title":"A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein\u2013Barr virus","volume":"5","author":"Sugden","year":"1985","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0285","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1128\/jvi.70.2.1228-1231.1996","article-title":"Cooperative assembly of EBNA1 on the Epstein\u2013Barr virus latent origin of replication","volume":"70","author":"Summers","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0290","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1073\/pnas.0910717107","article-title":"Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism","volume":"107","author":"Sun","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00571929","article-title":"An Epstein\u2013Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA","volume":"5","author":"Takada","year":"1991","journal-title":"Virus Genes"},{"key":"10.1016\/j.antiviral.2014.01.018_b0300","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1128\/JVI.02333-09","article-title":"Regulation of Epstein\u2013Barr virus OriP replication by poly(ADP-ribose) polymerase 1","volume":"84","author":"Tempera","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0305","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1087057110379154","article-title":"Development of a high-throughput screen for inhibitors of Epstein\u2013Barr virus EBNA1","volume":"15","author":"Thompson","year":"2010","journal-title":"J. Biomol. Scr."},{"key":"10.1016\/j.antiviral.2014.01.018_b0310","first-page":"651","article-title":"In situ demonstration of Epstein\u2013Barr viral genomes in viral-associated B cell lymphoproliferations","volume":"134","author":"Weiss","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0315","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/jvi.76.5.2480-2490.2002","article-title":"Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein\u2013Barr nuclear antigen 1","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.018_b0320","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/j.1349-7006.2011.02098.x","article-title":"DNA ligand designed to antagonize EBNA1 represses Epstein\u2013Barr virus-induced immortalization","volume":"102","author":"Yasuda","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.antiviral.2014.01.018_b0325","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1073\/pnas.81.12.3806","article-title":"A cis-acting element from the Epstein\u2013Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells","volume":"81","author":"Yates","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0330","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","article-title":"Stable replication of plasmids derived from Epstein\u2013Barr virus in various mammalian cells","volume":"313","author":"Yates","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.01.018_b0335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.virol.2005.11.021","article-title":"SiRNAs against the Epstein\u2013Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells","volume":"346","author":"Yin","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.01.018_b0340","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(86)90776-2","article-title":"Epstein\u2013Barr virus receptors on human pharyngeal epithelia","volume":"1","author":"Young","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.01.018_b0345","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","article-title":"Expression of Epstein\u2013Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease","volume":"321","author":"Young","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.01.018_b0350","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1073\/pnas.0510612103","article-title":"RNAs induced by Epstein\u2013Barr virus nuclear antigen 2 in lymphoblastoid cell lines","volume":"103","author":"Zhao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.01.018_b0355","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1128\/JVI.02378-08","article-title":"Protein array identification of substrates of the Epstein\u2013Barr virus protein kinase BGLF4","volume":"83","author":"Zhu","year":"2009","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:21Z","timestamp":1759062381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":71,"alternative-id":["S0166354214000308"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.01.018","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule inhibition of Epstein\u2013Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}